References
- Frizzera G, Moran E M, Rappaport H. Angioimmunoblastic lymphadenopathy with dysproteinemia. Lancet 1974; i: 1070–1073
- Lukes R J, Tindle B H. Immunoblastic lymphadenopathy: A hyperimmune disease entity resembling Hodgkin's disease. N Engl J Med 1975; 292: 1–8
- Palutke M, Khilanani P, Weise R. Immunologic and electron microscopic characteristics of a case of immunoblastic lymphadenopathy. Am J Clin Pathol 1976; 65: 929–941
- Shamoto M, Sucki T. Intracytoplasmic type A virus‐like particles in angioimmunoblastic lymphadenopathy. Cancer 1979; 44: 1641–1643
- Nathawani B N, Rappaport H, Moran E M, Pangalis G A, Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 1978; 41: 578–606
- Pangalis G A, Moran E M, Nathawani B N, Zelman R J. Kim H, Rappaport H: Angioimmunoblastic lymphadenopathy. Long‐term follow‐up study. 1983; 52: 318–321
- Nezelof C, Virelizier J L. Long‐lasting lymphadenopathy in childhood as an expression of a severe hyperimmune B lymphocyte disorder. Hematol Oncol 1983; 1: 227–242
- Stensvold K, Brandtzaeg P, Kvaloy S, Seip M, Lie S O. Immunoblastic lymphadenopathy with early onset in two boys: Immunohistochemical study and indication of decreased proportion of circulating T‐helper cells. Br J Haematol 1984; 56: 417–430
- Fiorillo A, Pettinato G, Raia V, Migliorati D, Angrisani P, Buffolano W. Angioimmunoblastic lymphadenopathy: Report of the first case in childhood evolving toward spontaneous remission. Cancer 1981; 48: 1611–1614
- Howarth C B, Bird C C. Immunoblastic sarcoma arising in child with immunoblastic lymphadenopathy. Lancet 1976; ii: 747–748, (letter)
- Bluming A Z, Cohen H G, Saxon A. Angioimmunoblastic lymphoadenopathy with dysproteinemia: A pathogenetic link between physiologic lymphoid proliferation and malignant lymphoma. Am J Med 1979; 67: 421–428
- Kosmidis P A, Axelrod A R, Palacas C, Stahl M. Angioimmunoblastic lymphadenopathy. A T‐cell deficiency. Cancer 1978; 42: 447–452
- Honda M, Smith H R, Steinberg A D. Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest 1985; 76: 332–340
- Ershler W B, Moore A L, Burns S L, Tindle B H. Immunoblastic lymphadenopathy: Failure of, rather than lack of, immunoregulation. J Med (Westbury) 1983; 14: 81–94
- Ellengaard J, Boesen A M. Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol 1976; 17: 36–43
- Bensa J C, Favre J, Martin H, Sotto J J, Schearer R. Levamisole and immunoblastic lymphadenopathy. Lancet 1976; i: 1081, (letter)
- Paloczi K, Suranyi P, Nemes Z, Szegedi G Y. A study of lymphocyte subsets in patients with angioimmunoblastic lymphadenopathy. Br J Hameatol 1986; 62: 615–618
- Bernego M G, Levi L, Zina G. Skin lesions in angioimmunoblastic lymphadenopathy: Histological and immunological studies. Br J Dermatol 1981; 104: 131–140
- Rudder R A, De Lellis R. Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol 1977; 68: 518–521
- Brincker H, Birkeland S A. The relationship between disease activity, treatment, response, and immunologic reactivity in immunoblastic lymphadenopathy: A longitudinal study of treatment with levamisole and cytostatics. Cancer 1981; 47: 266–271
- Rice L, Abramson S L, Laughter A H, Wheeler T M, Twomey J J. Angioimmunoblastic lymphadenopathy with hypogrammaglobulinemia. Possible role of monocyte suppression. Am J Med 1982; 72: 988–1004
- Kaneko Y, Larson R A, Variakojis D, Haren J M, Rowley J D. Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood 1982; 60: 877–887
- Godde‐Salz E, Feller A C, Lennert K. Chromosome abnormalities in lymphogranulomatosis (LgrX)/angioimmunoblastic lymphoadenopathy (AILD). Leuk Res 1987; 11: 181–190
- Minden M D, Mak T W. The structure of T cell antigen receptor genes in normal and malignant T cells. Blood 1986; 68: 327–336
- Caputo G, Leone G, Bizzi B. Effect of thymic extract (Tp1) in a case of angioimmunoblastic lymphadenopathy (AILD). Haematologica 1982; 67: 943–946
- Taylor S G. Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation. Med Pediatr Oncol 1981; 10: 171–174
- Goldstein G, Scheid M P, Boyse E A, Schlesinger D H, Van Wauwe J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 1979; 204: 1309–1310